新型电疗法可改善自身免疫性风湿性疾病患者的睡眠障碍
Jiaoshi Zhao1, Peili He1, Qiujing Wei1
1Department of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
International journal of rheumatic diseases
|June 4, 2024
概括
新型电疗法显著改善了自身免疫性风湿性疾病 (ARD) 患者的睡眠障碍. 这种治疗还调节了免疫细胞的百分比,并降低了特定的细胞因子水平,提供了新的治疗途径.
科学领域:
- 风湿病学和免疫学
- 睡眠医学 睡眠医学
- 新的治疗方式.
背景情况:
- 睡眠障碍是自身免疫性风湿性疾病 (ARD) 中普遍存在的问题,加剧了疾病活动并降低了生活质量.
- 了解睡眠,免疫功能和ARD中疾病活动之间的相互作用对于开发有效治疗方法至关重要.
研究的目的:
- 评估一种新型电疗法对治疗ARD患者睡眠障碍的有效性和可接受性.
- 评估这种电疗对关键免疫学因素的影响,包括细胞因子水平和免疫细胞群.
主要方法:
- 一项涉及51名睡眠障碍的ARD患者的研究,分为治疗组 (n=26) 和对照组 (n=25).
- 治疗组接受了新的电疗法 (15-30分钟,每天3-6次) 3个月,使用匹兹堡睡眠指数 (PSQI) 评估睡眠参数.
- 免疫功能和血清细胞因子水平 (12 种细胞因子) 在基线和治疗后使用流动细胞计和流动免疫光分析.
主要成果:
- 新型电疗法在3个月后显著改善了全球PSQI得分 (从12.81±4.07到4.88±2.76).
- 治疗导致血清IL-8和IL-1β水平显著下降.
- 观察到免疫细胞百分比的显著变化,包括CD4+CD8+T细胞,效能记忆CD8+T细胞,Th17细胞和血细胞的减少,以及天真CD8+T细胞,Th2细胞和Tfh2细胞的增加.
结论:
- 新型电疗法在改善ARD患者睡眠障碍方面表现出显著的有效性.
- 该疗法有效调节特定的血清细胞因子水平 (IL-8,IL-1β) 并改变各种免疫细胞群的百分比.
- 年龄被确定为ARD患者睡眠障碍的独立风险因素.
更多相关视频
相关概念视频
01:15REM Sleep Behavior Disorder
180
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
180
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
168
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
168
01:07Narcolepsy
101
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
101